Phoenix Select Regulatory Consulting Unveils New Brand Identity and Expanded GXP Services for Life Sciences

Phoenix Select abstract pattern dark background

Led by former FDA investigator Barbara Rusin, the firm introduces a refreshed brand and expanded capabilities focused on proactive quality, regulatory readiness, and informed decision-making.

EASTPOINTE, Mich. (October 30, 2026) – Phoenix Select Regulatory Consulting, an internationally recognized provider of GxP auditing, inspection readiness, and regulatory quality services for the life sciences industry, today announced the introduction of its refreshed brand identity, new website, and expanded service offerings to support pharmaceutical, biotechnology, and clinical research organizations (CROs) worldwide.

The updated brand reinforces Phoenix Select’s commitment to helping organizations identify potential regulatory risks early, strengthen quality systems, and make informed decisions throughout the drug development lifecycle. Built around the company’s guiding philosophy, Confidence in Every Audit™, the refreshed identity emphasizes the value of experienced regulatory oversight and quality practices that begin long before an inspection.

“The best time to identify a problem is before a regulator does,” said Barbara Rusin, MS, Founder and Chief Auditor of Phoenix Select Regulatory Consulting. “Having worked on the regulatory side, I have seen firsthand how gaps in processes, documentation, and oversight can affect development programs. Our goal is to help organizations recognize those risks early, build quality into their operations, and make better decisions based on dependable information.”

Expanded Services Supporting Quality Throughout Drug Development

As part of its continued growth, Phoenix Select has strengthened its service portfolio to address quality and compliance needs across the development lifecycle. Core capabilities include:

  • GxP Auditing – Independent assessments across clinical, non-clinical, laboratory, sponsor, CRO, vendor, and electronic system environments.
  • Inspection Readiness – Mock inspections, readiness assessments, and preparation for regulatory inspections conducted by agencies including the FDA, EMA, MHRA, PMDA, etc.
  • Remediation Services – Root cause analysis, corrective and preventive action support, and practical strategies for addressing regulatory observations and strengthening quality systems.
  • Quality Management Systems (QMS) & Training – Development and implementation of quality management systems, electronic systems, CAPA and event management, product complaint processes, quality documentation, and personnel training.

Phoenix Select also offers proprietary inspection readiness resources, including functional-area Regulator Questions and Issue Tracker and Storyboard templates. Developed using regulatory agency resources and decades of experience, these tools help cross-functional teams prepare for inspections, identify potential process gaps, and preserve critical organizational knowledge.

Built on Regulatory Experience and Personal Accountability

Phoenix Select is led by Rusin, whose career includes service as a Consumer Safety Officer with the U.S. Food and Drug Administration (FDA), where she worked as a Biologics Specialist, Bioresearch Monitoring Investigator, and Drug Investigator.

Her experience across basic medical, non-clinical, and clinical research has shaped the firm’s approach to quality oversight since it launched in early 2021. Phoenix Select works with a growing global network of qualified auditors, matching specialized expertise to the requirements of each engagement while maintaining direct senior oversight of audit deliverables.

“Quality decisions require quality data, and that principle guides everything we do,” added Rusin. “As Phoenix Select grows, we remain focused on bringing the right expertise to each engagement and helping our clients strengthen the systems and processes that support successful development programs.”

The refreshed brand represents Phoenix Select’s broader vision of helping bring safe and effective treatments to patients by supporting the quality and integrity of research throughout development.

To learn more about Phoenix Select Regulatory Consulting and its services, visit www.phoenixselect.com. 

About Phoenix Select Regulatory Consulting

Phoenix Select Regulatory Consulting provides GxP auditing, inspection readiness, regulatory consulting, remediation, and quality management system services to pharmaceutical, biotechnology, clinical research, and other life sciences organizations. Led by founder and Chief Auditor Barbara Rusin, MS, a former FDA investigator, Phoenix Select combines regulatory experience with a global network of qualified auditors to help organizations identify risks early, strengthen quality systems, and support informed decisions throughout the development lifecycle. Learn more at www.phoenixselect.com. 

Media Contact

Don F. McLean, McLean Media 

+1-734-716-4182